Physician profile
Janice E Eisleben
NPI 1669712147
$16,483.38
in general payments reported to CMS, 2019-2025
15 companies · $247 in 2025
The $247 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,302 · 2022: $6,483 · 2023: $6,160 · 2024: $290 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,520 · Food and Beverage: $988 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,519.79 |
| Food and Beverage | $988.48 |
| Education | $189.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $14,111.68 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $1,088.71 | 2021-2025 | Gardasil 9 |
| Astellas Pharma US INC | $440.21 | 2022-2025 | Veozah |
| Hologic Sales and Service, LLC | $180.13 | 2022-2025 | Aptima, Third Wave, Thinprep 2000 Processor |
| Bayer Healthcare Pharmaceuticals INC. | $129.24 | 2022-2025 | |
| Abbvie INC. | $108.56 | 2021-2023 | |
| Exeltis, USA INC. | $108.20 | 2022-2025 | Slynd |
| Sumitomo Pharma America, INC. | $85.98 | 2023-2025 | Myfembree |
| Pfizer INC. | $52.97 | 2023-2025 | |
| Mayne Pharma Commercial LLC | $47.94 | 2021-2023 | |
| Avion Pharmaceuticals | $41.68 | 2023 | Balcoltra |
| Myovant Sciences INC. | $34.37 | 2022 | |
| Millicent US INC | $19.49 | 2025 | Femlyv |
| Therapeuticsmd, INC. | $18.69 | 2022 | |
| Optumhealth Care Solutions, LLC | $15.53 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Eisleben listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.